ROBINS HARLAN S 4
4 · Adaptive Biotechnologies Corp · Filed Mar 6, 2025
Insider Transaction Report
Form 4
ROBINS HARLAN S
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-03-04+355,000→ 1,376,180 total - Sale
Common Stock
2025-03-05$6.99/sh−56,053$391,810→ 1,279,524 total - Sale
Common Stock
2025-03-05$6.98/sh−40,603$283,409→ 1,335,577 total
Footnotes (1)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.